Overview

Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
0
Participant gender:
Female
Summary
We aim to compare the effectiveness of cranberry capsules versus nitrofurantoin prophylaxis in preventing urinary tract infections (UTIs) after urogynecologic surgery by conducting a double-blinded randomized clinical trial involving women with pelvic organ prolapse and/or urinary incontinence scheduled to have surgery with the Urogynecologists who comprise the Brigham and Women's Urogynecology Group.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Brigham and Women's Hospital
Collaborator:
Theralogix LLC
Treatments:
Nitrofurantoin
Criteria
Inclusion Criteria:

- Age ≥ 18

- English-speaking

- Plan for POP or UI surgery

Exclusion Criteria:

- Pregnancy

- Urethral diverticulectomy

- Urogenital fistula repair

- Sacral neuromodulation

- Congenital urogenital anomaly

- Allergy to cranberry products

- Allergy to nitrofurantoin

- Dependent on catheterization preoperatively

- Recurrent UTI's (3 or more culture proven UTI's over the past consecutive 12 months)

- Known creatinine clearance <60 mL/min

- Non-English, Non-Spanish speaking